These unexpected events all involve direct transfers of P-gp to ABCB1/MDR1 non-expressing recipient cells from various multidrug resistance donors, namely adherent cell lines in vitro and in vivo [23], stromal cells isolated from patients suffering of ovarian cancers [24] and lymphoblastic leukemia cells in suspension [25]. Here, PGP is linked to ovarian carcinoma.